Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Minute Insight: Abbott Launches Mixed-Reality Experience To Make Blood Donation Easier

Executive Summary

Abbott will provide an immersive mixed reality experience for blood donors at Blood Centers of America. The company expects that making blood donation more pleasant will help to attract new donors and motivate a younger generation to give blood.

You may also be interested in...



Digital Health Roundup: CES 2023 Highlights; US FDA VR, AR Website; Bayer’s Powers Up On Radiology

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb provides highlights from the recent CES 2023 conference in Las Vegas. Reed Miller discusses Abbott’s VR partnership with the Blood Centers for America and Barnaby Pickering highlights Bayer’s jump into medtech with its buyout of Blackford Analysis.

CES 2023: Abbott, Seth Rogen, An Avatar For Old Folks, And A Smart Toilet For The Heartbroken

In this first roundup of innovative digital health solutions showcased at CES 2023, Medtech Insight highlights Abbott’s award-winning tech, an AARP-sponsored panel discussion on Alzheimer’s with Seth and Lauren Miller Rogen, Care.coach, and Casana, a smart toilet for monitoring patients with heart disease.

Cardio Conversations: ‘Much More Than Just A Patch,’ iRhythm CEO Blackford Talks AI Arrhythmia Diagnostics

iRhythm CEO Quentin Blackford returned to Medtech Insight’s Cardio Conversations podcast to talk about the launch of his company’s new Zio monitor patch supported by a sophisticated neural network. He also addressed the company’s plans to improve its position in the mobile cardiac telemetry market, the impact of pulsed field ablation on the cardiac monitoring business, and more.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147507

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel